Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead drug candidate, CardiolRxTM (cannabidiol) oral solut... Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead drug candidate, CardiolRxTM (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.15 | -11.5384615385 | 1.3 | 1.32 | 1.06 | 281725 | 1.16346785 | CS |
| 4 | -0.27 | -19.014084507 | 1.42 | 1.51 | 1.06 | 264359 | 1.26794985 | CS |
| 12 | -0.32 | -21.768707483 | 1.47 | 1.51 | 1.06 | 299183 | 1.3126841 | CS |
| 26 | -0.8 | -41.0256410256 | 1.95 | 2.63 | 1.06 | 392370 | 1.70756848 | CS |
| 52 | -0.59 | -33.908045977 | 1.74 | 3.12 | 1.06 | 391771 | 1.92304401 | CS |
| 156 | -0.4 | -25.8064516129 | 1.55 | 3.12 | 0.45 | 268452 | 1.49646745 | CS |
| 260 | -1.48 | -56.2737642586 | 2.63 | 4.96 | 0.45 | 330912 | 2.00047447 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
